Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Incidence, trends and demographics of Staphylococcus aureus infections in Auckland, New Zealand, 2001-2011.

Williamson DA, Lim A, Thomas MG, Baker MG, Roberts SA, Fraser JD, Ritchie SR.

BMC Infect Dis. 2013 Dec 3;13:569. doi: 10.1186/1471-2334-13-569.

2.

Incidence, risk factors, and outcomes of Panton-Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus infections in Auckland, New Zealand.

Muttaiyah S, Coombs G, Pandey S, Reed P, Ritchie S, Lennon D, Roberts S.

J Clin Microbiol. 2010 Oct;48(10):3470-4. doi: 10.1128/JCM.00911-10. Epub 2010 Aug 4.

3.

A comparison of methicillin-resistant and methicillin-susceptible Staphylococcus aureus reveals no clinical and epidemiological but molecular differences.

Jiménez JN, Ocampo AM, Vanegas JM, Rodriguez EA, Mediavilla JR, Chen L, Muskus CE, Vélez LA, Rojas C, Restrepo AV, Garcés C, Kreiswirth BN, Correa MM.

Int J Med Microbiol. 2013 Mar;303(2):76-83. doi: 10.1016/j.ijmm.2012.12.003. Epub 2013 Jan 29.

PMID:
23369303
4.

Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection.

Filice GA, Nyman JA, Lexau C, Lees CH, Bockstedt LA, Como-Sabetti K, Lesher LJ, Lynfield R.

Infect Control Hosp Epidemiol. 2010 Apr;31(4):365-73. doi: 10.1086/651094.

PMID:
20184420
5.

The clinical and molecular epidemiology of Staphylococcus aureus infections in Fiji.

Jenney A, Holt D, Ritika R, Southwell P, Pravin S, Buadromo E, Carapetis J, Tong S, Steer A.

BMC Infect Dis. 2014 Mar 24;14:160. doi: 10.1186/1471-2334-14-160.

6.

The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study.

Laupland KB, Lyytikäinen O, Søgaard M, Kennedy KJ, Knudsen JD, Ostergaard C, Galbraith JC, Valiquette L, Jacobsson G, Collignon P, Schønheyder HC; International Bacteremia Surveillance Collaborative.

Clin Microbiol Infect. 2013 May;19(5):465-71. doi: 10.1111/j.1469-0691.2012.03903.x. Epub 2012 May 23.

7.

Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.

Laupland KB, Ross T, Gregson DB.

J Infect Dis. 2008 Aug 1;198(3):336-43. doi: 10.1086/589717.

PMID:
18522502
8.
9.

Molecular surveillance and population structure analysis of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in high-risk wards.

Sergi S, Donnarumma F, Mastromei G, Goti E, Nicoletti P, Pecile P, Cecconi D, Mannino R, Fanci R, Bosi A, Bartolozzi B, Casalone E.

J Clin Microbiol. 2009 Oct;47(10):3246-54. doi: 10.1128/JCM.00624-09. Epub 2009 Aug 5.

10.

Community-associated, methicillin-susceptible, and methicillin-resistant Staphylococcus aureus bone and joint infections in children: experience from India.

Kini AR, Shetty V, Kumar AM, Shetty SM, Shetty A.

J Pediatr Orthop B. 2013 Mar;22(2):158-66. doi: 10.1097/BPB.0b013e32835c530a.

PMID:
23249998
11.
12.

Clinical isolates of Staphylococcus aureus from the Arkhangelsk region, Russia: antimicrobial susceptibility, molecular epidemiology, and distribution of Panton-Valentine leukocidin genes.

Vorobieva V, Bazhukova T, Hanssen AM, Caugant DA, Semenova N, Haldorsen BC, Simonsen GS, Sundsfjord A.

APMIS. 2008 Oct;116(10):877-87. doi: 10.1111/j.1600-0463.2008.01092.x.

PMID:
19132981
13.

Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children.

Hultén KG, Kaplan SL, Gonzalez BE, Hammerman WA, Lamberth LB, Versalovic J, Mason EO Jr.

Pediatr Infect Dis J. 2006 Apr;25(4):349-53.

PMID:
16567988
14.

[Trends in Staphylococcus aureus antimicrobials susceptibilities: is methicillin still a relevant multiresistance marker?].

Grohs P.

Pathol Biol (Paris). 2009 Feb;57(1):1-8. doi: 10.1016/j.patbio.2008.05.010. Epub 2008 Jun 30. French.

PMID:
18586411
15.

All Wales surveillance of methicillin-resistant Staphylococcus aureus (MRSA): the first year's results.

Morgan M, Salmon R, Keppie N, Evans-Williams D, Hosein I, Looker DN.

J Hosp Infect. 1999 Mar;41(3):173-9.

PMID:
10204119
16.

Feedback to clinicians on preventable factors can reduce hospital onset Staphylococcus aureus bacteraemia rates.

Kok J, O'Sullivan MV, Gilbert GL.

J Hosp Infect. 2011 Oct;79(2):108-14. doi: 10.1016/j.jhin.2011.04.023. Epub 2011 Jul 8.

PMID:
21741724
17.

Molecular characterization and susceptibility of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from hospitals and the community in Vladivostok, Russia.

Baranovich T, Zaraket H, Shabana II, Nevzorova V, Turcutyuicov V, Suzuki H.

Clin Microbiol Infect. 2010 Jun;16(6):575-82. doi: 10.1111/j.1469-0691.2009.02891.x. Epub 2009 Aug 4.

18.

Decreasing incidence of Staphylococcus aureus bacteremia over 9 years: greatest decline in community-associated methicillin-susceptible and hospital-acquired methicillin-resistant isolates.

Khatib R, Sharma M, Iyer S, Fakih MG, Obeid KM, Venugopal A, Fishbain J, Johnson LB, Segireddy M, Jose J, Riederer K.

Am J Infect Control. 2013 Mar;41(3):210-3. doi: 10.1016/j.ajic.2012.03.038. Epub 2012 Oct 4.

PMID:
23040608
19.

Community-associated Panton-Valentine leukocidin-negative meticillin-resistant Staphylococcus aureus clone (ST72-MRSA-IV) causing healthcare-associated pneumonia and surgical site infection in Korea.

Joo EJ, Chung DR, Ha YE, Park SY, Kang SJ, Kim SH, Kang CI, Peck KR, Lee NY, Ko KS, Song JH.

J Hosp Infect. 2012 Jul;81(3):149-55. doi: 10.1016/j.jhin.2012.04.018. Epub 2012 May 30.

PMID:
22652522
20.

Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.

Skiest DJ, Brown K, Cooper TW, Hoffman-Roberts H, Mussa HR, Elliott AC.

J Infect. 2007 May;54(5):427-34. Epub 2006 Oct 27.

PMID:
17070598

Supplemental Content

Support Center